Ribozyme treatment of diseases or conditions related to...

Details Ribozyme treatment of diseases or conditions related to... Ribozyme treatment of diseases or conditions related to...

C - Chemistry, Metallurgy

12

N

C12N 15/11 (2006.01) A61K 31/70 (2006.01) C07H 21/02 (2006.01) C12N 5/10 (2006.01) C12N 9/22 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2199727

Enzymatic RNA molecules which cleave apo(a) mRNA. Use of these catalytic RNA molecules for the treatment of conditions related to lipoprotein A levels, such as atherosclerosis, myocardial infarction, strokes; testenosis and heart diseases.

Molécules enzymatiques d'ARN assurant le clivage de l'ARNm apo(a). Utilisation de ces molécules d'ARN catalytiques pour traiter des états liés au niveau des lipoprotéines A, tels que l'athérosclérose, l'infarctus du myocarde, les ictus, la resténose et les troubles cardiaques.

Affiliated with

Also associated with

Rating

Ribozyme treatment of diseases or conditions related to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ribozyme treatment of diseases or conditions related to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribozyme treatment of diseases or conditions related to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1373645